Quantitative structure-activity relationship studies of cyclooxygenase inhibitors: A comprehensive analysis

被引:8
|
作者
Prasanna, S [1 ]
Manivannan, E [1 ]
Chaturvedi, SC [1 ]
机构
[1] Sch Pharm, Indore 452017, India
关键词
QSAR; COX-1; COX-2; Clogp; CMR;
D O I
10.1002/ddr.10432
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A quantitative structure-activity relationship (QSAR) analysis of 10 structurally diverse set of compounds recently reported as cyclooxygenase (COX) inhibitors has been performed using ClogP, CMR, aromatic substituent constants, and suitable indicator variables. These revealed several important physicochemical and structural requirements for COX-1, COX-2 inhibitory activity, and selective inhibition of COX-2 versus COX-1 among these novel ligands. Seventeen QSAR models reported herein provide interesting insights in understanding the hydrophobic, steric, electronic, and structural requirements of COX inhibition among these individual set of compounds. These results may be used to further the design and development of selective COX-2 inhibitors among these newly reported COX inhibitors.(c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:220 / 231
页数:12
相关论文
共 50 条
  • [1] Three dimensional quantitative structure-activity relationship of cyclooxygenase-2 inhibitors
    Guo, YS
    Chu, FM
    Guo, ZR
    Bai, AP
    ACTA CHIMICA SINICA, 2003, 61 (07) : 1114 - 1120
  • [2] Quantitative structure-activity relationship studies of mushroom tyrosinase inhibitors
    Xue, Chao-Bin
    Luo, Wan-Chun
    Ding, Qi
    Liu, Shou-Zhu
    Gao, Xing-Xiang
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2008, 22 (05) : 299 - 309
  • [3] Diarylspiro[2.4]heptenes as selective cyclooxygenase-2 inhibitors: A quantitative structure-activity relationship analysis
    Kumar, R
    Singh, P
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 1997, 36 (12): : 1164 - 1168
  • [4] Dihydroorotate Dehydrogenase Inhibitors: Quantitative Structure-activity Relationship Analysis
    Shijun Ren
    Sharon K. Wu
    Eric J. Lien
    Pharmaceutical Research, 1998, 15 : 286 - 295
  • [5] Dihydroorotate dehydrogenase inhibitors: Quantitative structure-activity relationship analysis
    Ren, SJ
    Wu, SK
    Lien, EJ
    PHARMACEUTICAL RESEARCH, 1998, 15 (02) : 286 - 295
  • [6] Quantitative structure-activity relationship analysis of β-amyloid aggregation inhibitors
    Stempler, Shiri
    Levy-Sakin, Michal
    Frydman-Marom, Anat
    Amir, Yaniv
    Scherzer-Attali, Roni
    Buzhansky, Ludmila
    Gazit, Ehud
    Senderowitz, Hanoch
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2011, 25 (02) : 135 - 144
  • [7] QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDIES ON PROSTAGLANDIN SYNTHETASE (PGS) INHIBITORS
    GUPTA, SP
    PRABHAKAR, YS
    SINGH, P
    CURRENT SCIENCE, 1987, 56 (21): : 1090 - 1092
  • [8] Quantitative structure-activity relationship analysis of canonical inhibitors of serine proteases
    Dell'Orco, Daniele
    De Benedetti, Pier Giuseppe
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2008, 22 (6-7) : 469 - 478
  • [9] Quantitative structure-activity relationship and molecular docking studies on designing inhibitors of the perforin
    Song, Fucheng
    Cui, Lianhua
    Piao, Jinmei
    Liang, Hui
    Si, Hongzong
    Duan, Yunbo
    Zhai, Honglin
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (04) : 535 - 544
  • [10] Quantitative Structure-Activity Relationship (QSAR) studies of carbonic anhydrase inhibitors and activators
    Khadikar, Padmakar V.
    Supuran, Claudiu T.
    Das Manikpuri, Anju
    Singh, Shalini
    Lakhwani, Meenakshi
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2011, 88 (01) : 25 - 85